News Oct 2, 2024
Safer Psychedelic Drugs May Be Coming
External link
News Sep 30, 2024
MDMA Drug Developers Reprioritize Following Lykos Rejection in PTSD
External link
News Sep 13, 2024
Neurocrine’s bid to save schizophrenia prospect fails
External link
News Aug 17, 2024
How the next psychedelics companies believe they can avoid Lykos’ fate
External link
News Aug 14, 2024
Atai’s DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
External link
News Aug 13, 2024
Atai Touts Early Data on Psychedelic Depression Drug, Plans Phase II Trial
External link
News Aug 13, 2024
Atai advances oral psychedelic in depression
External link
News Aug 12, 2024
FDA rejected MDMA-assisted PTSD therapy. Other psychedelics firms intend to avoid that fate
External link
News Jul 23, 2024
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
External link